Stem cell (SC) yield and transplantation results from transplant-eligible newly diagnosed multiple myeloma (TE NDMM) patients (pts) receiving daratumumab (DARA) plus bortezomib/thalidomide/dexamethasone (D-VTd) in the phase 3 CASSIOPEIA study.

Affiliation auteurs!!!! Error affiliation !!!!
TitreStem cell (SC) yield and transplantation results from transplant-eligible newly diagnosed multiple myeloma (TE NDMM) patients (pts) receiving daratumumab (DARA) plus bortezomib/thalidomide/dexamethasone (D-VTd) in the phase 3 CASSIOPEIA study.
Type de publicationJournal Article
Year of Publication2019
AuteursHulin C, Moreau P, Attal M, Belhadj K, Benboubker L, Caillot D, Facon T, Garderet L, Kuhnowski F, Stoppa A-M, Kolb B, Tiab M, Sonneveld P, Jie K-S, Westerman M, Pei L, Kampfenkel T, de Boer C, Vermeulen J, van de Donk NWCJ
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume37
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X